140412-90-4 Usage
### Properties
1. Chemical Name: 2-amino-7-methyl-10-propyldibenzo[b,f][1,4]oxazepin-11(10H)-one
2. Chemical Formula: C??H??N?O
3. Type: Tricyclic antidepressant
4. Mechanism of Action: Acts as a serotonin and norepinephrine reuptake inhibitor
5. Use: Treatment of major depressive disorder, generalized anxiety disorder, and other mood disorders
6. Mode of Action: Increases levels of serotonin and norepinephrine in the brain
7. Benefits: Improves mood, reduces anxiety, alleviates depressive symptoms
8. Side Effects:
Drowsiness
Dizziness
Constipation
Sexual dysfunction
9. Caution: Should be used under the supervision of a doctor
Type
Tricyclic antidepressant
Mechanism of Action
Acts as a serotonin and norepinephrine reuptake inhibitor
Use
Treatment of major depressive disorder, generalized anxiety disorder, and other mood disorders
Mode of Action
Increases levels of serotonin and norepinephrine in the brain
Benefits
Improves mood, reduces anxiety, alleviates depressive symptoms
Side Effects
Drowsiness
Dizziness
Constipation
Sexual dysfunction
Caution
Should be used under the supervision of a doctor
This compound is known for its pharmaceutical properties and is used in the treatment of various mood disorders. It works by affecting neurotransmitters in the brain, but it also comes with potential side effects that should be monitored by a healthcare professional.
Check Digit Verification of cas no
The CAS Registry Mumber 140412-90-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,0,4,1 and 2 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 140412-90:
(8*1)+(7*4)+(6*0)+(5*4)+(4*1)+(3*2)+(2*9)+(1*0)=84
84 % 10 = 4
So 140412-90-4 is a valid CAS Registry Number.
140412-90-4Relevant articles and documents
Novel Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase. 2. Tricyclic Pyridobenzoxazepinones and Dibenzoxazepinones
Klunder, Janice M.,Hargrave, Karl D.,West, MaryAnn,Cullen, Ernest,Pal, Kollol,et al.
, p. 1887 - 1897 (2007/10/02)
Dibenzoxazepin-11(10H)-ones (III), pyridobenzoxazepin-6(5H)-ones (IV), and pyridobenzoxazepin-5(6H)-ones (V) were found to inhibit human immunodeficiency virus type 1 reverse transcriptase with IC50 values as 19 nM.A-ring substitution has a profound effect on activity, with appropriate substituents at the positions ortho and para to the lactam nitrogen providing dramatically enhanced potency.Substitution in the C-ring is generally neutral or detrimental to activity.Although a C-ring amino substituent at the position meta to the lactam carbonyl is generally beneficial to activity, it has essentially no effect when the A-ring is optimally substituted.Like the dipyridodiazepinone nevirapine, compounds III-V are specific for HIV-1 RT, exhibiting no inhibitory activity against HIV-2 RT or other virial reverse transcriptase enzymes.